Aspirin and Cancer – the emerging evidence

Published by Peter Elwood on

Aspirin and the Prevention of Cancer: The Emerging Evidence – Cardiff University School of Medicine.

Categories: Articles

Related Posts

Articles

The Aspirin and Cancer Paradox: unlocking the global potential of aspirin for vascular disease and cancer management

by The Welsh Aspirin Group Peter Elwood, Gareth Morgan, Richard Adams, Christine Delon, Marcus Longley, Simon Noble, Janet Pickering, Majd Protty, John Watkins, Anna Yeatman Corresponding author: Gareth Morgan ABSTRACT:   Aspirin is a remarkable drug Read more

Articles

The current therapeutic role of aspirin in cancer patients

Myeloproliferative neoplasms (MPN’s) are a group of blood cancers.  MPN’s are bone marrow disorders which results in an excess of blood cells.  As a result, these blood cancers are associated with risks of clots and Read more

Articles

A Summary of the evidence of ad hoc randomised controlled trials of aspirin and cancer treatment

Addendum: Since publishing this article, two trials have been subsequently published on aspirin and bowel cancer.  They have mixed results and neither study found a statistically significant effect.  The table and the commentary will be Read more